GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Therapeutics Corp (BSP:U2TH34) » Definitions » Land And Improvements

United Therapeutics (BSP:U2TH34) Land And Improvements : R$1,108 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is United Therapeutics Land And Improvements?

United Therapeutics's land and improvements for the quarter that ended in Mar. 2025 was R$1,108 Mil.

United Therapeutics's quarterly land and improvements increased from Sep. 2024 (R$903 Mil) to Dec. 2024 (R$1,110 Mil) but then declined from Dec. 2024 (R$1,110 Mil) to Mar. 2025 (R$1,108 Mil).

United Therapeutics's annual land and improvements declined from Dec. 2022 (R$749 Mil) to Dec. 2023 (R$725 Mil) but then increased from Dec. 2023 (R$725 Mil) to Dec. 2024 (R$1,110 Mil).


United Therapeutics Land And Improvements Historical Data

The historical data trend for United Therapeutics's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Land And Improvements Chart

United Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Land And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 385.34 749.84 748.52 725.17 1,109.77

United Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 758.42 823.54 903.22 1,109.77 1,108.43

United Therapeutics Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


United Therapeutics Business Description

Traded in Other Exchanges
Address
1000 Spring Street, Silver Spring, MD, USA, 20910
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

United Therapeutics Headlines

No Headlines